Gold prices slip after rallying on Powell rate cut talk
DELRAY BEACH, Fla. and OAKLAND, Calif. - PetMed Express, Inc. (NASDAQ:PETS), a leading pet healthcare provider with annual revenue of $247 million, has announced a strategic partnership with Dutch, a virtual veterinary care provider. This collaboration aims to enhance the accessibility of pet healthcare by integrating Dutch’s telemedicine services with PetMeds’ extensive medication offerings. According to InvestingPro analysis, PetMeds maintains a strong financial position with more cash than debt on its balance sheet, suggesting stability for future growth initiatives.
The partnership responds to a critical vet shortage impacting over 129 million Americans, as reported by Dutch’s 2025 State of Veterinary Care Report. Pet parents can now access Dutch’s virtual care platform, which includes 24/7 appointments with veterinarians in 34 states, and secure prescriptions for PetMeds’ medications. Dutch has facilitated nearly 700,000 visits and provides treatment options for more than 150 conditions. InvestingPro data shows PetMeds maintains a healthy current ratio of 1.43, indicating strong ability to meet short-term obligations while expanding services.
Joe Spector, Founder and CEO of Dutch, emphasized the partnership’s role in addressing care gaps due to the nationwide vet shortage. He expressed enthusiasm about reaching more pet parents in need. Sandra Campos, President and CEO of PetMeds, highlighted the importance of veterinarians in pet healthcare and noted that the partnership would support Dutch’s 200 employed veterinarians and ensure continuity of care.
PetMed Express, founded in 1996, operates as an online retailer offering pharmaceuticals, compounded medications, and OTC supplements for pets. Dutch, launched in July 2021, has grown to serve over 40,000 customers and treats a wide range of conditions.
The collaboration is poised to offer pet owners a more affordable, accessible way to maintain their pets’ health, especially in areas underserved by traditional veterinary clinics. Dutch’s memberships start at $15/month and provide unlimited access to their services, excluding insurance.
The information for this article is based on a press release statement from PetMed Express, Inc. For comprehensive analysis of PetMeds’ financial health and growth potential, including 12 additional exclusive ProTips and detailed valuation metrics, visit InvestingPro, where you’ll find expert insights and the complete Pro Research Report.
In other recent news, PetMed Express reported third-quarter earnings that did not meet Wall Street expectations, with earnings per share at ($0.03) compared to the anticipated ($0.01). Revenue also fell short, coming in at $53 million against an expected $65 million. Despite the earnings miss, the company improved its gross margin rate to 28.1% and increased its adjusted EBITDA to $2 million from $0.9 million year-over-year. Morgan Stanley analysts have adjusted their outlook on PetMed Express, reducing the price target from $3.50 to $3.20 while maintaining an Underweight rating due to competitive pressures in the sector. The company has also seen changes in its leadership, with the appointment of Peter Batushansky to the Board of Directors and the upcoming retirement of Dr. Gian Fulgoni. Additionally, PetMed Express is undergoing a transformation, focusing on operational efficiency and customer engagement, as highlighted by CEO Sandra Campos. Analysts, including Ryan Meyers from Lake Street, remain cautious about the company’s near-term prospects, noting ongoing competitive challenges and the need for strategic improvements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.